Log in to save to my catalogue

A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection

A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4856222

A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection

About this item

Full title

A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection

Publisher

Washington: American Association for the Advancement of Science

Journal title

Science (American Association for the Advancement of Science), 2015-04, Vol.348 (6230), p.136-139

Language

English

Formats

Publication information

Publisher

Washington: American Association for the Advancement of Science

More information

Scope and Contents

Contents

Immune cells, including natural killer (NK) cells, recognize transformed cells and eliminate them in a process termed immunosurveillance. It is thought that tumor cells evade immunosurveillance by shedding membrane ligands that bind to the NKG2D-activating receptor on NK cells and/or T cells, and desensitize these cells. In contrast, we show that i...

Alternative Titles

Full title

A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4856222

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4856222

Other Identifiers

ISSN

0036-8075

E-ISSN

1095-9203

DOI

10.1126/science.1258867

How to access this item